Research Associate 2, Operations Sustaining
Personalis, Inc
Summary
The Research Associate 2, Operations Sustaining will provide operational and technical support for clinical lab products with focus on NeXT Personal Dx, Personalis' ultrasensitive molecular residual disease assay. The role involves partnering with a cross-functional team to triage and resolve order and sample related issues and support process improvement and scalability opportunities.
Job description
Summary
The Research Associate 2, Operations Sustaining will provide operational and technical support for clinical lab products with focus on NeXT Personal Dx, Personalis' ultrasensitive molecular residual disease assay. The role involves partnering with a cross-functional team to triage and resolve order and sample related issues and support process improvement and scalability opportunities.
Responsibilities
- Participate in clinical laboratory sustaining support activities, including but not limited to tracking clinical sample and pipeline issues, troubleshooting, and documenting root cause and resolution.
- Follow written procedure to update sample status and workflow to unblock stalled samples or address special sample movement requests.
- Collaborate with lab operations, client experience, clinical software, data management, pipeline, and quality teams to address sample processing or pipeline failures and customer requests.
- Partner with cross-functional teams to implement workflow improvements to support product growth.
- Additional responsibilities may include remote weekend lab sustaining support.
Education & Experience
- A Bachelor's degree in a molecular biology or related field with a minimum of 3 years of relevant experience; or a master's degree and 1 or more years of relevant experience.
- Working knowledge in Next Generation Sequencing technology, LIMS, and SFDC. Experience with molecular residual disease assay is a plus.
- Familiarity with operations of high throughput clinical laboratory including sample accessioning, sample processing, pipeline analysis, and report release.
- Highly organized and systematic, with superb attention to detail and the ability to prioritize and complete tasks with a high degree of accuracy.
- Demonstrated quick learner and skilled in analytical thinking, utilizing data to drive decisions.
Requirements
- Bachelor's degree in molecular biology or related field with minimum 3 years of relevant experience; or master's degree with 1 or more years of relevant experience
- Working knowledge in Next Generation Sequencing technology, LIMS, and SFDC
- Familiarity with operations of high throughput clinical laboratory including sample accessioning, sample processing, pipeline analysis, and report release
- Highly organized and systematic with superb attention to detail
- Ability to prioritize and complete tasks with a high degree of accuracy
- Skilled in analytical thinking, utilizing data to drive decisions
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- ESPP
- Tuition Reimbursement
- Sick/Vacation Time
- Commuter Benefits
- EV Charging Stations
- Onsite Gym
- Wellness Benefits
- Annual Performance-Based Bonus
- Long-Term Incentive Units
Company overview
Personalis, Inc. is a pioneering cancer genomics company that is transforming the active management of cancer through breakthrough personalized testing solutions. Founded in 2011 and headquartered in Fremont, California, the company specializes in developing ultrasensitive circulating tumor DNA (ctDNA) assays for cancer detection and monitoring. Personalis's flagship NeXT Platform provides comprehensive molecular data about each patient's cancer and immune response, analyzing all approximately 20,000 human genes from a single tissue sample. The company's innovative NeXT Personal test enables highly sensitive detection of minimal residual disease (MRD) and cancer recurrence, often months to years ahead of standard imaging techniques. Personalis collaborates with biopharmaceutical companies to advance cancer therapies and personalized medicine, with its CLIA-certified and CAP-accredited laboratory processing over 200,000 whole-genome sequencing samples for major research programs like the U.S. Department of Veterans Affairs Million Veteran Program. The company's technology is particularly focused on immuno-oncology applications, tumor profiling, and personalized cancer vaccine development.